Global Phage Therapy Market - PowerPoint PPT Presentation

About This Presentation
Title:

Global Phage Therapy Market

Description:

Global phage therapy market is expected to foresee a compound annual growth rate of 8.1% from 2021 to 2028. The major factors driving the growth of the phage therapy market are antibiotics resistance, the increased prevalence of food-borne diseases, use of phage therapy in the food & beverage industry, application of bacteriophage specific to target bacteria, extensive research & development, and increasing antimicrobial resistance. Nowadays antibiotics resistance has become one of the biggest threats to global health as it can affect people of any age group. – PowerPoint PPT presentation

Number of Views:19

less

Transcript and Presenter's Notes

Title: Global Phage Therapy Market


1
Global Phage Therapy Market
  • (Bacteriophage Market Virus Campylobacter,
    Salmonella, Escherichia coli, Listeria,
    Klebsiella, and Staphylococcus spp., Key Players
    Armata Pharmaceuticals, Inc, Micreos,
    TechnoPhage) Industry Scenario, Market Size,
    Outlook, Trend and Forecast 2019 2028

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
2
Global Phage Therapy Market
  • Global phage therapy market is expected to
    foresee a compound annual growth rate of 8.1
    from 2021 to 2028. The major factors driving the
    growth of the phage therapy market
    are antibiotics resistance, the increased
    prevalence of food-borne diseases, use of phage
    therapy in the food beverage industry,
    application of bacteriophage specific to target
    bacteria, extensive research development, and
    increasing antimicrobial resistance. Nowadays
    antibiotics resistance has become one of the
    biggest threats to global health as it can affect
    people of any age group. Misuse and overuse of
    antibiotics by people is leading to antibiotic
    resistance. Hence, scientists across the globe
    are expecting that the traditional use of
    antibiotics would be replaced by modernized
    bacteriophages or phage therapies. Also, few
    people are allergic to antibiotics as a result
    phage therapy could be a useful alternative for
    such patients.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
3
  • Phage therapy also known as Bacteriophage is
    specific to the bacteria they infect and do not
    harm other beneficial bacteria present in the
    body and affect the microbial ecosystem of the
    body. Bacteriophages can be administrated to
    patients in many different ways which include
    oral consumption, external application, and
    surgical treatment. Phages consist mostly of
    nucleic acids and proteins thus they are
    inherently non-toxins. Bacteriophages against
    many bacteria are easily discovered and
    additionally, they are versatile in terms of
    formulation development which includes the
    ability to get combined with any other
    antibiotics. Furthermore, the production of phage
    therapy is simple and relatively inexpensive.
    Clinical trials of bacteriophage to cure diseases
    such as HIV Infection, Wound Infections, Urinary T
    ract Infection Bacterial, Acute Tonsillitis,
    Venous Leg Ulcers, Covid19, Tuberculosis, Cystic
    Fibrosis, Mild Gastrointestinal, Primary Immune
    Deficiency Diseases, Bacterial Infections,
    Prostate Cancer and many others are being
    conducted in future, bacteriophage therapy could
    replace antibiotic treatments of these diseases.
    Bacteriophages therapies are still under clinical
    trials and company pipelines, hence it cannot be
    claimed to be entirely reliable. In addition,
    bacteriophages are viruses that tend to swap
    genes with each other and other organisms with
    which they come into contact. Hence, there is a
    chance of the spread of antibiotic resistance in
    bacteria. These are some of the factors that
    would slightly slow down the acceptance in the
    phage therapy market.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
4
  • Bacteriophage plays a significant role in the
    food industry due to the increased prevalence of
    food-borne diseases that are caused due to food
    spoilage and this is boosting the growth of the
    bacteriophage market, as spoiled food contains
    pathogenic bacteria and viruses. The interest in
    characteristic antimicrobial builds has expanded
    because of changes in shopper positions towards
    the utilization of substance additives in staple
    and food handling surfaces. Bacteriophages fit in
    the class of characteristic antimicrobial and
    their adequacy in controlling bacterial microbes
    in the agro-food industry has prompted the
    advancement of various phage items previously
    endorsed by USFDA and USDA.
  • Bacteriophages are highly specific to target
    bacteria
  • and bacteriophages do not affect human cells
  • directly. The primary bit of scope is the
    explicitness
  • of bacteriophages and medicines that can be
  • intended to explicitly target pathogenic
  • microorganisms while not adversely influencing
    the
  • ordinary microbiota. Another possible issue with
    phage
  • treatment incorporates the improvement of
    resistance and
  • constraints with the enrolment of phage treatment
  • alternatives. Increased antimicrobial resistance
    in
  • bacteriophage therapy is driving the global
    bacteriophage
  • therapy market growth. For instance, in 2017, the
    World
  • Health Organization (WHO) published a list of
    global priority
  • pathogens comprising 12 species of bacteria
    categorized into critical, high, and medium
    priority based on their level of resistance. It
    is believed that bacteriophage therapy would be
    replacing the traditional use of antibiotics as
    extensive use of antibiotics is increasing the
    risk of antimicrobial resistance.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
5
  • The major limiting component for the
    development/extension of the worldwide phage
    therapy market is the absence of prepared
    technicians, experts, and specialists in the
    field. In addition, the high risk of product
    failure for drug development is another factor
    restraining the market growth. Several companies
    operating in the bacteriophage therapy market are
    investing and focusing on developing advanced
    bacteriophage platforms. In addition, the
    emerging economy is providing booming
    opportunities in the global bacteriophage market,
    as there has been an increase in the patient
    population in the health care sector. For
    instance, Armata Pharmaceuticals, Inc. Adaptive
    Phage Therapeutics, Phagelux, SNIPR BIOME,
    Microgen Russia, BiomX (MBcure Ltd.), Enbiotix,
    Eligo Bioscience, MicroPhage Inc., Phage
    International, Intralytix, Inc, InnoPhage,
    iNtODEWorld, Locus Biosciences among others are
    the leading players in the global bacteriophage
    market.
  • North America holds a substantial share in the
    global phage therapy market, inferable from the
    increment in bacteriophage clinical path. For
    example, as per UC San Diego Health 2019
    investigation, the U.S. Food and Drug
    Administration (USFDA) has given leeway for the
    clinical path in the U.S. to test IV directed
    bacteriophage-based treatment to execute drug
    opposition.
  • The global phage therapy market is segmented
    into by bacteria, by product, by application,
    and geography Geographically, North America is
    anticipated to have the largest market share over
    the next seven years and the growth is attributed
    to the early adoption of new and emerging
    technologies coupled with expanding volumes of
    data. However, Asia Pacific is expected to
    witness the highest compound annual growth rate
    (CAGR) in the Phage Therapy market. The major
    geographies covered under the scope of Global
    Phage Therapy are North America, Asia Pacific,
    Europe, and the Rest of the Global (RoW). North
    America is further segmented into the U.S.,
    Mexico, and Canada. Europe is segmented into the
    UK, Germany, France, Italy, Spain, and the Rest
    of Europe. The key countries covered under the
    Asia Pacific are Japan, China, India, South
    Korea, Australia, and the Rest of the Asia
    Pacific. Similarly, the Rest of the World (RoW)
    is bifurcated into South Central America,
    Middle East, and Africa.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
6
  • Armata Pharmaceuticals, Inc. Adaptive Phage
    Therapeutics, Phagelux, SNIPR BIOME, Microgen
    Russia, BiomX (MBcure Ltd.), Enbiotix, Eligo
    Bioscience, MicroPhage Inc., Phage International,
    Intralytix, Inc, InnoPhage, iNtODEWorld, Locus
    Biosciences, PhagoMed Biopharma GmbH, Pherecydes
    Pharma SA, TechnoPhage, Eliava Biopreparations
    Ltd., Nextbiotics, PhagePro, Inc, Phi
    Therapeutics, Fixed-phage Ltd, Micreos BV and
    ContraFect Corporation are the prominent players
    of the global bacteriophages market.
  • Years Covered in the Report 2019 - 2028
  • Base Year 2020
  • Forecast Years 2021 - 2028

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
7
Scope of Global Phage Therapy Market/
Bacteriophage Market
  • HUMAN PHAGE THERAPY DISEASES AND BACTERIA BY
    REGION, 2021 2027
  • LIST OF PHAGE THERAPY PIPELINE
  • The market is segmented on the basis of by
    Bacteria, Product, by Application, and by Region.
  • Market Segmentation by Bacteria (Revenue, USD
    Million, 2019 - 2028)
  • Salmonella
  • Streptococcus
  • Escherichia Coli
  • Others
  • Market Segmentation by Product (Revenue, USD
    Million, 2019 - 2028)
  • Oral Consumption
  • External applications
  • Surgical treatment

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
8
Market Segmentation by Region/ Geography/ Country
(Revenue, USD Million, 2019 - 2028)
  • Market Segmentation by Product (Revenue, USD
    Million, 2019 - 2028)
  • Oral Consumption
  • External applications
  • Surgical treatment
  • Market Segmentation by Application (Revenue, USD
    Million, 2019 - 2028)
  • Human medicines
  • Veterinary science
  • Food
  • Others (Agriculture, dentistry, etc.)

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
9
Asia PacificChinaJapanIndiaSouth
KoreaTaiwanSingaporeAustraliaRest of Asia
PacificRest of the World (RoW)Central South
AmericaMiddle EastAfrica
Market Segmentation by Region/ Geography/ Country
(Revenue, USD Million, 2019 - 2028)
  • North America
  • The U.S.
  • Mexico
  • Canada
  • Europe
  • The U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Belgium
  • Switzerland
  • Netherlands
  • Rest of Europe

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
10
Contact Us
  • Accurize Market Research Pvt. Ltd.
  • PATNA OFFICE K-129,
  • PC COLONY,
  • HANUMAN NAGAR,
  • KANKARBAGH, PATNA, PIN-800020
  • Emailhelp_at_accurizemarketresearch.com
  • CONTACT NO1-339-368-6383

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
Write a Comment
User Comments (0)
About PowerShow.com